Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13337108 | 0.80 | — | — | |
| SCHEMBL13673856 | 0.80 | — | — | |
| SCHEMBL28385888 | 0.80 | — | — | |
| SCHEMBL13673906 | 0.80 | — | — | |
| SCHEMBL16562296 | 0.80 | — | — | |
| SCHEMBL19934655 | 0.79 | — | — | |
| Ammonia Solution, Strong SCHEMBL10763153 | 0.77 | ALDH1A1 (0.45) | ALDH1A1 | |
| SCHEMBL28845338 | 0.75 | ALDH1A1 (0.35) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL10754291 | 0.75 | — | — | |
| SCHEMBL187701 | 0.75 | ALDH1A1 (0.43) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1620066-A2 | ORAL CARE METHODS AND PRODUCTS | DMI Biosciences, Inc. (US) | 2006-02-01 | — | — | EP | claimed |
| WO-2004100884-A2 | ORAL CARE METHODS AND PRODUCTS | DMI BIOSCIENCES, INC. (US) | 2004-11-25 | — | — | WO | claimed |
| US-20050002876-A1 | Oral care methods and products | AMPIO PHARMACEUTICALS, INC. | 2005-01-06 | — | — | US | disclosed |
| EP-0705250-A1 | BIS-IMIDE POLYCYCLIC AND HETEROCYCLIC CHROMOPHORES USEFUL AS TUMORICIDALS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-04-10 | — | — | EP | disclosed |